Company · CIK 1858848

# Tenaya Therapeutics, Inc.

| CIK | [1858848](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001858848) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | TNYA (Nasdaq) |
| First annual or quarterly report | 2021-09-08 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-286005 | Shelf Effective | 2025-03-21 | 2025-12-12 | 4 |
| 333-266741 | Shelf Effective | 2022-08-10 | 2025-03-04 | 8 |
| 333-257820 | IPO Final prospectus | 2021-07-09 | 2021-07-30 | 4 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-12 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312525317609/0001193125-25-317609-index.htm) Shelf takedown | 333-286005 | 0001193125-25-317609 |
| 2025-12-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312525316104/0001193125-25-316104-index.htm) Shelf takedown | 333-286005 | 0001193125-25-316104 |
| 2025-03-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1858848/999999999525000905/9999999995-25-000905-index.htm) Declared effective | 333-286005 | 9999999995-25-000905 |
| 2025-03-21 | [S-3](https://www.sec.gov/Archives/edgar/data/1858848/000119312525060227/0001193125-25-060227-index.htm) Shelf registered | 333-286005 | 0001193125-25-060227 |
| 2025-03-04 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312525045610/0001193125-25-045610-index.htm) Shelf takedown | 333-266741 | 0001193125-25-045610 |
| 2025-03-03 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312525044134/0001193125-25-044134-index.htm) Shelf takedown | 333-266741 | 0001193125-25-044134 |
| 2024-02-08 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312524028514/0001193125-24-028514-index.htm) Shelf takedown | 333-266741 | 0001193125-24-028514 |
| 2022-11-17 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312522287677/0001193125-22-287677-index.htm) Shelf takedown | 333-266741 | 0001193125-22-287677 |
| 2022-11-16 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312522286840/0001193125-22-286840-index.htm) Shelf takedown | 333-266741 | 0001193125-22-286840 |
| 2022-08-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1858848/999999999522002422/9999999995-22-002422-index.htm) Declared effective | 333-266741 | 9999999995-22-002422 |
| 2022-08-17 | [424B5](https://www.sec.gov/Archives/edgar/data/1858848/000119312522223273/0001193125-22-223273-index.htm) Shelf takedown | 333-266741 | 0001193125-22-223273 |
| 2022-08-10 | [S-3](https://www.sec.gov/Archives/edgar/data/1858848/000119312522217445/0001193125-22-217445-index.htm) Shelf registered | 333-266741 | 0001193125-22-217445 |
| 2021-07-30 | [424B4](https://www.sec.gov/Archives/edgar/data/1858848/000119312521231612/0001193125-21-231612-index.htm) Final prospectus | 333-257820 | 0001193125-21-231612 |
| 2021-07-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1858848/999999999521002984/9999999995-21-002984-index.htm) Declared effective | 333-257820 | 9999999995-21-002984 |
| 2021-07-26 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1858848/000119312521223559/0001193125-21-223559-index.htm) Amendment | 333-257820 | 0001193125-21-223559 |
| 2021-07-09 | [S-1](https://www.sec.gov/Archives/edgar/data/1858848/000119312521212010/0001193125-21-212010-index.htm) Registration filed | 333-257820 | 0001193125-21-212010 |
| 2021-05-07 | [DRS](https://www.sec.gov/Archives/edgar/data/1858848/000095012321005602/0000950123-21-005602-index.htm) Draft made public | 377-04815 | 0000950123-21-005602 |

[All filings of this company](https://equitycapital.markets/filings?cik=1858848) · [CSV](https://equitycapital.markets/filings.csv?cik=1858848)

---
Source page: https://equitycapital.markets/company/1858848 · Data: U.S. SEC EDGAR · CC BY 4.0